Literature DB >> 20652685

Identification and quantification of salinomycin in intoxicated human plasma by liquid chromatography-electrospray tandem mass spectrometry.

Yu Li1, Junjian Fang, Shengming Wu, Kunpeng Ma, Haijing Li, Xianzhong Yan, Fangting Dong.   

Abstract

Salinomycin is a polyether ionophore antibiotic that is widely used in poultry and livestock. Exposure of humans to salinomycin via inhalation or ingestion can cause severe toxicity. The aim of the present work was to develop a simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the rapid identification and quantification of salinomycin in human plasma. After removing protein using methanol, plasma samples were eluted from a Waters Xterra(®) MS C18 column with an isocratic mobile phase. Detection and quantification of the drug were performed with a triple-quadruple mass spectrometer by monitoring for two specific transitions in the electrospray, positive-ion, multiple-reaction monitoring mode. Assay validation showed good linearity (r(2) = 0.998). The detection and quantification limits of the method were 0.6 and 16 pg/mL, respectively. The inter- and intraday coefficients of variation for the assay were both <15%. Twelve authentic plasma samples from intoxicated patients were analyzed using this method. Salinomycin was detected in six samples, at concentrations of between 0.6 and 46.5 pg/mL. The described assay method allows the sensitive and rapid identification and quantification of salinomycin in human plasma, and thus provides a valuable tool for the specific diagnosis of salinomycin intoxication in clinical and emergency rescue practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652685     DOI: 10.1007/s00216-010-3999-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  5 in total

1.  Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas.

Authors:  Devraj Basu; Kathleen T Montone; Li-Ping Wang; Phyllis A Gimotty; Rachel Hammond; J Alan Diehl; Anil K Rustgi; John T Lee; Kati Rasanen; Gregory S Weinstein; Meenhard Herlyn
Journal:  Cell Cycle       Date:  2011-06-15       Impact factor: 4.534

2.  Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice.

Authors:  Wolfgang Boehmerle; Hanna Muenzfeld; Andreas Springer; Petra Huehnchen; Matthias Endres
Journal:  J Mol Med (Berl)       Date:  2014-04-27       Impact factor: 4.599

3.  Salinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells.

Authors:  Andressa Megumi Niwa; Gláucia Fernanda Rocha D Epiro; Lilian Areal Marques; Simone Cristine Semprebon; Daniele Sartori; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-02       Impact factor: 3.000

4.  Targeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cells.

Authors:  Elaine A Dunlop; Charlotte E Johnson; Marie Wiltshire; Rachel J Errington; Andrew R Tee
Journal:  Oncotarget       Date:  2017-07-25

5.  Ionophore Toxin Maduramicin Produces Haff Disease-Like Rhabdomyolysis in a Mouse Model.

Authors:  Xiuge Gao; Xinhao Song; Runan Zuo; Dan Yang; Chunlei Ji; Hui Ji; Lin Peng; Yawei Qiu; Dawei Guo; Shanxiang Jiang
Journal:  Int J Environ Res Public Health       Date:  2020-10-27       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.